New and developing therapies for atopic dermatitis

Detalhes bibliográficos
Autor(a) principal: Hajar,Tamar
Data de Publicação: 2018
Outros Autores: Gontijo,João Renato Vianna, Hanifin,Jon M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000100104
Resumo: Abstract: Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.
id SBD-1_695d928cfe48fd2c05c03a0bc691a6f8
oai_identifier_str oai:scielo:S0365-05962018000100104
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling New and developing therapies for atopic dermatitisDermatitis, atopicEczemaPhosphodiesterase inhibitorsTherapeuticsAbstract: Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.Sociedade Brasileira de Dermatologia2018-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000100104Anais Brasileiros de Dermatologia v.93 n.1 2018reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20187682info:eu-repo/semantics/openAccessHajar,TamarGontijo,João Renato ViannaHanifin,Jon M.eng2018-03-29T00:00:00Zoai:scielo:S0365-05962018000100104Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2018-03-29T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv New and developing therapies for atopic dermatitis
title New and developing therapies for atopic dermatitis
spellingShingle New and developing therapies for atopic dermatitis
Hajar,Tamar
Dermatitis, atopic
Eczema
Phosphodiesterase inhibitors
Therapeutics
title_short New and developing therapies for atopic dermatitis
title_full New and developing therapies for atopic dermatitis
title_fullStr New and developing therapies for atopic dermatitis
title_full_unstemmed New and developing therapies for atopic dermatitis
title_sort New and developing therapies for atopic dermatitis
author Hajar,Tamar
author_facet Hajar,Tamar
Gontijo,João Renato Vianna
Hanifin,Jon M.
author_role author
author2 Gontijo,João Renato Vianna
Hanifin,Jon M.
author2_role author
author
dc.contributor.author.fl_str_mv Hajar,Tamar
Gontijo,João Renato Vianna
Hanifin,Jon M.
dc.subject.por.fl_str_mv Dermatitis, atopic
Eczema
Phosphodiesterase inhibitors
Therapeutics
topic Dermatitis, atopic
Eczema
Phosphodiesterase inhibitors
Therapeutics
description Abstract: Atopic dermatitis is a common inflammatory skin disease. New understanding in disease pathogenesis has led to a considerable number of promising new drugs in development. New topical agents can be especially helpful for children, providing an alternative to the need for chronic topical corticosteroid use. While many patients with mild or moderate disease can be managed with topical treatments, there are unmet needs for recalcitrant and severe cases. New and developing therapies hold promise for real advances in management of this complex disease.
publishDate 2018
dc.date.none.fl_str_mv 2018-02-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000100104
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962018000100104
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20187682
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.93 n.1 2018
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126422592258048

Registros relacionados